200 related articles for article (PubMed ID: 23448878)
1. Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation.
Hellberg L; Samavedam UKSRL; Holdorf K; Hänsel M; Recke A; Beckmann T; Steinhorst K; Boehncke WH; Kirchner T; Möckel N; Solbach W; Zillikens D; Schmidt E; Ludwig RJ; Laskay T
J Invest Dermatol; 2013 Oct; 133(10):2390-2399. PubMed ID: 23448878
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita.
Tukaj S; Hellberg L; Ueck C; Hänsel M; Samavedam U; Zillikens D; Ludwig RJ; Laskay T; Kasperkiewicz M
Exp Dermatol; 2015 Jun; 24(6):471-3. PubMed ID: 25739426
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids in autoimmune bullous diseases: are neutrophils the key cellular target?
Simon D; Borradori L; Simon HU
J Invest Dermatol; 2013 Oct; 133(10):2314-2315. PubMed ID: 24030648
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage.
Chiriac MT; Roesler J; Sindrilaru A; Scharffetter-Kochanek K; Zillikens D; Sitaru C
J Pathol; 2007 May; 212(1):56-65. PubMed ID: 17380558
[TBL] [Abstract][Full Text] [Related]
6. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita.
Koga H; Recke A; Vidarsson G; Pas HH; Jonkman MF; Hashimoto T; Kasprick A; Ghorbanalipoor S; Tenor H; Zillikens D; Ludwig RJ
J Invest Dermatol; 2016 Nov; 136(11):2211-2220. PubMed ID: 27388992
[TBL] [Abstract][Full Text] [Related]
7. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.
Karsten CM; Beckmann T; Holtsche MM; Tillmann J; Tofern S; Schulze FS; Heppe EN; Ludwig RJ; Zillikens D; König IR; Köhl J; Schmidt E
Front Immunol; 2018; 9():488. PubMed ID: 29599777
[TBL] [Abstract][Full Text] [Related]
8. Dimethylfumarate Impairs Neutrophil Functions.
Müller S; Behnen M; Bieber K; Möller S; Hellberg L; Witte M; Hänsel M; Zillikens D; Solbach W; Laskay T; Ludwig RJ
J Invest Dermatol; 2016 Jan; 136(1):117-26. PubMed ID: 26763431
[TBL] [Abstract][Full Text] [Related]
9. The Leukotriene B
Sezin T; Krajewski M; Wutkowski A; Mousavi S; Chakievska L; Bieber K; Ludwig RJ; Dahlke M; Rades D; Schulze FS; Schmidt E; Kalies K; Gupta Y; Schilf P; Ibrahim SM; König P; Schwudke D; Zillikens D; Sadik CD
J Invest Dermatol; 2017 May; 137(5):1104-1113. PubMed ID: 28108297
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
[TBL] [Abstract][Full Text] [Related]
11. The Syk Tyrosine Kinase Is Required for Skin Inflammation in an In Vivo Mouse Model of Epidermolysis Bullosa Acquisita.
Németh T; Virtic O; Sitaru C; Mócsai A
J Invest Dermatol; 2017 Oct; 137(10):2131-2139. PubMed ID: 28576735
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Glucose Metabolism Abrogates the Effector Phase of Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.
Schilf P; Schmitz M; Derenda-Hell A; Thieme M; Bremer T; Vaeth M; Zillikens D; Sadik CD
J Invest Dermatol; 2021 Jul; 141(7):1646-1655.e3. PubMed ID: 33609554
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases.
Tukaj S; Zillikens D; Kasperkiewicz M
Exp Dermatol; 2015 Aug; 24(8):567-71. PubMed ID: 25980533
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil Adhesion Is a Prerequisite for Antibody-Mediated Proteolytic Tissue Damage in Experimental Models of Epidermolysis Bullosa Acquisita.
Yu X; Akbarzadeh R; Pieper M; Scholzen T; Gehrig S; Schultz C; Zillikens D; König P; Petersen F
J Invest Dermatol; 2018 Sep; 138(9):1990-1998. PubMed ID: 29559343
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of indirect immunofluorescence on sodium chloride-split skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita.
Yang B; Wang C; Chen S; Chen X; Zhou G; Tian H; Yu M; Zhang D; Shi Z; Zhang F
Indian J Dermatol Venereol Leprol; 2011; 77(6):677-82. PubMed ID: 22016274
[TBL] [Abstract][Full Text] [Related]
17. GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita.
Samavedam UK; Iwata H; Müller S; Schulze FS; Recke A; Schmidt E; Zillikens D; Ludwig RJ
J Immunol; 2014 Jan; 192(2):559-71. PubMed ID: 24337383
[TBL] [Abstract][Full Text] [Related]
18. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
[TBL] [Abstract][Full Text] [Related]
19. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.
Bieber K; Witte M; Sun S; Hundt JE; Kalies K; Dräger S; Kasprick A; Twelkmeyer T; Manz RA; König P; Köhl J; Zillikens D; Ludwig RJ
Sci Rep; 2016 Dec; 6():38357. PubMed ID: 27917914
[TBL] [Abstract][Full Text] [Related]
20. Immobilized immune complexes induce neutrophil extracellular trap release by human neutrophil granulocytes via FcγRIIIB and Mac-1.
Behnen M; Leschczyk C; Möller S; Batel T; Klinger M; Solbach W; Laskay T
J Immunol; 2014 Aug; 193(4):1954-65. PubMed ID: 25024378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
